Dr Adam Glen is the Founder of several scientific and engineering businesses.  Principally Unicorn Biotechnologies ("The Nvidia of cell Biology") and its spin-out, Dragon Biotechnologies ("Cell line engineering and start-up tailored CRO service company"). 

After spending >15 years in R&D and commercial roles at various large/spin-out companies and Universities, Adam grew frustrated with the lack of translation of academic research and the significant barriers facing the adoption of mammalian cell-based technology.  Principally that of reproducibility, speed and cost. 

Since building and testing prototypes in his attic 3.5 years ago.  Unicorn Biotechnologies has grown to a multinational company with presence in both the UK and the US, built multiple labs, and most recently executed the worlds first conversion of a former nightclub into a 5000-square-foot facility biotech/engineering facility. 

Adam has raised ~$4 million in venture capital investment, won several Innovate UK grant awards (>$2 million), and built a nimble and efficient team of exceptional scientists/engineers.  Who have gone on to build and patent (written themselves) an end-to-end automated cell culture R&D and manufacturing platform, with products crossing hardware, wetware, cell lines and media and being sold internationally across 4 continents. 

Adam is a no-nonsense, plain-speaking person who is also a passionate advocate for empowering more Scientists/Engineers turned CXOs/company builders and holds an Entrepreneur in Residence Fellowship from the Royal Society in combination with being a member of the Royal Academy of Engineering Hub.